Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

NCT03948724 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

411

Enrollment

OTHER

Sponsor class

Conditions

Therapeutic Patient Education
Immune Checkpoint Inhibitors
Melanoma
Advanced Non-small Cell Lung Cancer
Renal Cell Carcinoma
Head and Neck Cancer
Immune-related Adverse Event

Interventions

BEHAVIORAL: Therapeutic education program
BEHAVIORAL: Usual Information

Sponsor

Institut Cancerologie de l'Ouest